Oxford BioMedica PLC
OXOA
Company Profile
Business description
Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types.
Contact
Windrush Court
Transport Way
OxfordOX4 6LT
GBRT: +44 1865783000
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
900
Stocks News & Analysis
stocks
Undervalued ASX retailer benefiting from rebound in spending
Uplift in sales momentum continues.
stocks
Undervalued ASX share searches for cost savings
Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks
Chart of the Week: Where we see opportunities after year end market sell-off
The latest insights from our equity research team.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,983.30 | 28.90 | 0.32% |
| CAC 40 | 8,134.07 | 48.31 | 0.60% |
| DAX 40 | 24,359.95 | 65.34 | 0.27% |
| Dow JONES (US) | 48,704.01 | 646.26 | 1.34% |
| FTSE 100 | 9,724.69 | 21.53 | 0.22% |
| HKSE | 25,976.79 | 446.28 | 1.75% |
| NASDAQ | 23,593.86 | 60.30 | -0.25% |
| Nikkei 225 | 50,836.55 | 687.73 | 1.37% |
| NZX 50 Index | 13,406.91 | 11.04 | 0.08% |
| S&P 500 | 6,901.00 | 14.32 | 0.21% |
| S&P/ASX 200 | 8,697.30 | 32.40 | 0.37% |
| SSE Composite Index | 3,889.35 | 16.03 | 0.41% |